What You Should Know: - Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, and Verily Life Sciences LLC (Verily), a precision health technology company, have teamed up to launch a groundbreaking research initiative called "My Mental Health Journey." - The longitudinal registry study aims to significantly enhance our understanding of depression and other mental health conditions. The Power of Real-World Data My Mental
Read More
Verily
Verily & L’Oreal Launches Diverse Skin and Hair Health Registry
What You Should Know: Today, Verily and L’Oreal announced the launch of a multi-year study, My Skin & Hair Journey, to advance precision skin and hair health. This is part of the two companies' multi-year partnership and research collaboration. The My Skin & Hair Journey registry will enroll thousands of self-identifying U.S. women to develop an unprecedented body of knowledge about perceptions and experiences of skin and hair health, including the role of lifestyle,
Read More
Digital Health Exec Hires: Transcarent Appoints CMO, Carium, Tegria, Swift Medical, GoCheckKids, Others
Transcarent appoints Dr. Randy Hawkins as Chief Medical Officer (CMO) and will report to Transcarent Chief Executive Officer, Glen Tullman. As CMO, Dr. Hawkins will oversee the organization’s clinical quality initiatives and support the organization’s health analytics strategy. Swift Medical has appointed Brian Litten as its new Chief Executive Officer effective immediately. Litten brings decades of healthcare leadership experience across health plans, provider organizations, regulatory
Read More
The Quickening Pulse of the Ambulatory Diagnostic Cardiology Market
The Global Ambulatory Diagnostic Cardiology Market is evolving at a rapid pace, driven by technological developments, and shifting models of healthcare service delivery and funding. The overall market will grow from $2.5 billion in 2021, to $3.3 billion by 2026, with Long-Term ECG and, to a lesser extent, Mobile Cardiac Telemetry (MCT), being the principal engines of growth. Unsurprisingly, these two markets are garnering serious attention from large incumbent vendors in the more established
Read More
22 Executive Digital Health Predictions to Watch in 2023
Jon Bloom, MD, CEO and Co-founder of Podimetrics From a digital health perspective, 2022 was a reset year for many and a serious reality check. We went from sky high growth to the sky is falling, and in 2023 I think this market correction movement will continue forward. To me, the biggest surprise of 2022 was that despite the market tanking, digital health companies continued to truck forward with huge deals. This includes massive acquisitions like Amazon and OneMedical, as well as deals like
Read More
HLTH22 Day 3 News Summary
DispatchHealth Raises $330M for Hospital-at-Home Care DispatchHealth, a provider of in-home medical care raises $330M led by Optum Ventures with support from current investors such as Humana (NYSE: HUM), Oak HC/FT, Echo Health Ventures and Questa Capital. New investors included Adams Street Partners, the Olayan Group, Silicon Valley Bank, Pegasus Tech Ventures and Blue Shield of California. Patients and their care partners can request DispatchHealth medical care via phone, mobile app, or
Read More
Dexcom G7 Blood Glucose Monitoring Launches in 5 Global Markets
What You Should Know: - Dexcom announced launch of Dexcom G7 continuous glucose monitoring (CGM) system in the United Kingdom, Ireland, Germany, Austria and Hong Kong, with launches in New Zealand and South Africa in the coming weeks – initiating the global rollout of the world’s most powerful CGM system. - Dexcom G7 offers a powerful yet simple way to help users gain greater control of their diabetes, so they can manage the disease more confidently each day. Its
Read More
FDA Awards 510(k) Clearances for ZEUS System/Zio Watch
What You Should Know: - Today, iRhythm (a digital health company) and Verily (Alphabet’s life sciences research organization) announced joint FDA 510(k) clearances for the ZEUS System and Zio Watch. Together they create an integrated, prescription-based solution that will improve clinician workflows, care pathways and the patient experience. - The ZEUS System is the AI algorithm and solution component of the Zio Watch – a clinical grade, long-term and noninvasive wearable that not only
Read More
Day 3 HIMSS Roundup: Glooko Acquires DIABNEXT, GE Healthcare/AliveCor Integration
Venture Capital, Private Equity, Mergers & Acquisitions (M&A) Activity Glooko Acquires DIABNEXT® to Expand Diabetes Offerings in France Glooko, a leading provider of remote patient monitoring and data management solutions for diabetes and related chronic conditions, today announced the acquisition of DIABNEXT, a Paris-based company whose digital health platform helps people with diabetes better manage their conditions and connects to their healthcare providers, so they can
Read More
Verily & Lumea Partner to Leverage AI in Prostate Cancer Diagnoses
What You Should Know: - Verily and Lumea today announced a strategic partnership to develop products that can diagnose, prognose, and guide prostate cancer therapy selection with improved objectivity and efficiency. - Lumea’s integrated digital pathology solution will validate Verily’s AI method for improving cancer detection and grading in partnership with Google Health. Partnership Goals The Verily-Lumea collaboration will utilize Lumea’s digital pathology platform
Read More
